IRIS

Martini, V., Minotti, C., Breccia, M., Angelis, G., Buffolino, S., Mariella, M., et al. (2007). Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid [2]. ANNALS OF HEMATOLOGY, 86(4), 295-297 [10.1007/s00277-006-0219-9].

Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid [2]

LO COCO, FRANCESCO;
2007-01-01
2007
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arsenicals; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oncogene Proteins, Fusion; Oxides; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Tretinoin
Martini, V., Minotti, C., Breccia, M., Angelis, G., Buffolino, S., Mariella, M., et al. (2007). Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid [2]. ANNALS OF HEMATOLOGY, 86(4), 295-297 [10.1007/s00277-006-0219-9].
Martini, V; Minotti, C; Breccia, M; Angelis, G; Buffolino, S; Mariella, M; LO COCO, F; Avvisati, G; Cimino, G
Articolo su rivista
01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/162137
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact